DIACEUTICS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 103.5 GBX | +0.49% |
|
-0.48% | +18.97% |
| Apr. 02 | Roadside shares suspended; Adnams looks for funds | AN |
| Mar. 21 | Diaceutics upgrades diagnositc commercialisation platform, DXRX | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Diaceutics PLC is a United Kingdom-based company, which is a provider of technology and solutions. The Company provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. The Company operates through three segments: Insight Solutions (Data), Engagement Solutions (Tech enabled services), and Advisory Services (Professional services). The Companyâs DXRX - The Diagnostics Network is a diagnostic commercialization platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of laboratories. It provides unrivalled access to multiple pipelines of real-world diagnostic testing data from a global network of laboratories. Its Tech Enabled Services offers clinical testing labs to provide enablement and educational services in novel biomarkers.
Sector
Business Support Services
Calendar
2024-05-21
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.035
GBP
Average target price
1.666
GBP
Spread / Average Target
+60.97%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +18.97% | 108M | |
| +2.00% | 3.9B | |
| +18.72% | 1.88B | |
| -4.30% | 1.75B | |
| +1.08% | 1.61B | |
| -22.53% | 1.51B | |
| -28.81% | 1.32B | |
| -11.71% | 1.15B | |
| -8.49% | 972M | |
| +119.33% | 694M |
- Stock Market
- Equities
- DXRX Stock
- News Diaceutics PLC
- Earnings Flash (DXRX.L) DIACEUTICS Posts FY21 Revenue GBP13.9M
